Pfizer plots Saudi Arabian manufacturing plant

Pfizer ($PFE) has inked a deal to build a new manufacturing plant in Saudi Arabia that will produce and package drugs beginning in 2015 with the help of as many as 200 workers. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.